<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">02391</article-id><article-id pub-id-type="doi">10.7554/eLife.02391</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biophysics and Structural Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Re-examining how complexin inhibits neurotransmitter release: SNARE complex insertion or electrostatic hindrance?</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-9320"><name><surname>Trimbuch</surname><given-names>Thorsten</given-names></name><aff><addr-line><named-content content-type="department">NeuroCure Cluster of Excellence, Neuroscience Research Center</named-content></addr-line>, <institution>Charité-Universitätsmedizin Berlin</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10868"><name><surname>Xu</surname><given-names>Junjie</given-names></name><aff><addr-line><named-content content-type="department">Department of Biophysics</named-content></addr-line>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10869"><name><surname>Flaherty</surname><given-names>David</given-names></name><aff><addr-line><named-content content-type="department">Department of Biophysics</named-content></addr-line>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4335"><name><surname>Tomchick</surname><given-names>Diana R</given-names></name><aff><addr-line><named-content content-type="department">Department of Biophysics</named-content></addr-line>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1815"><name><surname>Rizo</surname><given-names>Josep</given-names></name><aff><addr-line><named-content content-type="department">Department of Biophysics</named-content></addr-line>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country><email>jose@arnie.swmed.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-1175"><name><surname>Rosenmund</surname><given-names>Christian</given-names></name><aff><addr-line><named-content content-type="department">NeuroCure Cluster of Excellence, Neuroscience Research Center</named-content></addr-line>, <institution>Charité-Universitätsmedizin Berlin</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf2"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1054"><name><surname>Brunger</surname><given-names>Axel T</given-names></name><role>Reviewing editor</role><aff><institution>Stanford University</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>05</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e02391</elocation-id><supplementary-material><ext-link xlink:href="elife-02391-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>24</day><month>01</month><year>2014</year></date><date date-type="accepted"><day>06</day><month>05</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Trimbuch et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Trimbuch et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Complexins play activating and inhibitory functions in neurotransmitter release. The complexin accessory helix inhibits release and was proposed to insert into SNARE complexes to prevent their full assembly. This model was supported by 'superclamp' and 'poor-clamp' mutations that enhanced or decreased the complexin-I inhibitory activity in cell-cell fusion assays, and by the crystal structure of a superclamp mutant bound to a synaptobrevin-truncated SNARE complex. NMR studies now show that the complexin-I accessory helix does not insert into synaptobrevin-truncated SNARE complexes in solution, and electrophysiological data reveal that superclamp mutants have slightly stimulatory or no effects on neurotransmitter release, whereas a poor-clamp mutant inhibits release. Importantly, increasing or decreasing the negative charge of the complexin-I accessory helix inhibits or stimulates release, respectively. These results suggest a new model whereby the complexin accessory helix inhibits release through electrostatic (and perhaps steric) repulsion enabled by its location between the vesicle and plasma membranes.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Christian Rosenmund, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animals were handled according to the animal welfare committee of the Charit� Berlin, Germany. Time pregnant females were anesthetized and euthanized at E18 according to the german animal law ({section sign}4 section 1) and permit by the Berlin authorities (Landesamt f�r Gesundheit und Soziales, LaGeSo) under the permit number T0220/09.</p></fn></fn-group></back></article>